Ckw Financial Group Editas Medicine, Inc. Transaction History

Ckw Financial Group

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$26.55 - $40.57 $18,770 - $28,682	-707 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$39.27 - $72.94 $27,763 - $51,568	707 New	707 $28,000
Q2 2021 Aug 05, 2021	SELL	$31.29 - $56.64 $31,290 - $56,640	-1,000 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$39.71 - $90.58 $39,710 - $90,580	1,000 New	1,000 $42,000
Q4 2020 Feb 10, 2021	SELL	$27.07 - $84.35 $1,840 - $5,735	-68 Closed	0 $0
Q3 2020 Nov 10, 2020	BUY	$28.06 - $37.16 $1,908 - $2,526	68 New	68 $2,000

244

58.9M

494K

417K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $208M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Ckw Financial Group, based on Form 13F filings with the SEC.

Stay updated on Ckw Financial Group with notifications on news.